Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic double-agents unmasked

26.10.2004


Babraham Institute and Cancer Research UK scientists have discovered that certain enzymes with a key activity in the immune system may be important in stem-cell development, but may also work against us by contributing to the occurrence of cancer.

The usual targets

A family of enzymes known as DNA deaminases beneficially mutates the genetic code of antibodies to improve their ability to recognise foreign bodies. The usual target for the enzymes’ activity is cytosine (C), one of the four building blocks of DNA, however this research has shown that the enzymes can also target another DNA component: methylcytosine (cytosine carrying a methyl chemical group).



Double-agents

The discovery may help to explain how methylcytosine is removed from DNA in naturally-occurring situations, such as stem-cell development, but it also suggests a possible mechanism for the mutations that occur in up to one third of hereditary diseases and many cancers. Hence DNA deaminases may be acting as ‘double-agents’.

Dr Wolf Reik, Head of Developmental Genetics and Imprinting at the Babraham Institute, explains: “The removal of methyl groups from DNA is a sought-after activity implicated in the ability of stem-cells to develop into any other cell in the body, but it is uncertain how this demethylation could occur. The activity we have found in DNA deaminases provides a potential explanation of the mechanism. However, incorrect repair of the DNA during this process may result in mutations that could increase a person’s chance of developing cancer.”

Interpreting the code

Methylcytosine is an example of an ‘epigenetic’ mark – a heritable modification of DNA that affects the way in which a gene is read, without changing the DNA code itself. Epigenetics is an important area of research because epigenetic marks are essential for normal development and they can become misdirected in the cell, leading to cancer and other human diseases.

The discovery of the actions of these enzymes, described in a paper published in the Journal of Biological Chemistry, was made by Dr Hugh Morgan and colleagues, working with Dr Wolf Reik at the Babraham Institute, and in collaboration with Dr Svend Peterson-Mahrt at Cancer Research UK.

Emma Southern | alfa
Further information:
http://www.babraham.ac.uk

More articles from Life Sciences:

nachricht At last, butterflies get a bigger, better evolutionary tree
16.02.2018 | Florida Museum of Natural History

nachricht New treatment strategies for chronic kidney disease from the animal kingdom
16.02.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

Im Focus: Autonomous 3D scanner supports individual manufacturing processes

Let’s say the armrest is broken in your vintage car. As things stand, you would need a lot of luck and persistence to find the right spare part. But in the world of Industrie 4.0 and production with batch sizes of one, you can simply scan the armrest and print it out. This is made possible by the first ever 3D scanner capable of working autonomously and in real time. The autonomous scanning system will be on display at the Hannover Messe Preview on February 6 and at the Hannover Messe proper from April 23 to 27, 2018 (Hall 6, Booth A30).

Part of the charm of vintage cars is that they stopped making them long ago, so it is special when you do see one out on the roads. If something breaks or...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Fingerprints of quantum entanglement

16.02.2018 | Information Technology

'Living bandages': NUST MISIS scientists develop biocompatible anti-burn nanofibers

16.02.2018 | Health and Medicine

Hubble sees Neptune's mysterious shrinking storm

16.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>